|
TAKE THIS POLL |
|
|
- Follow Up: For Gilead, Growth Beyond AIDS 30 Jun 2008 05:15 GMT
... 22% and an earnings gain of 19%. HIV-treatment drugs delivered more than two-thirds of Gilead's '07 ... recent studies show that HIV drugs containing abacavir, including GlaxoSmithKline's (GSK) Epzicom, can have dangerous ...
- For Gilead, Growth Beyond AIDS 30 Jun 2008 05:15 GMT
... 22% and an earnings gain of 19%. HIV-treatment drugs delivered more than two-thirds of Gilead's '07 ... recent studies show that HIV drugs containing abacavir, including GlaxoSmithKline's (GSK) Epzicom, can have dangerous ...
1 - 2 of 2
News by PR Newswire
|
| Tip of the day
Related Newsletters
Come and Visit
|
|
| | |